Effects of channel modulators on cloned large-conductance calcium- activated potassium channels

VK Gribkoff, JT Lum-Ragan, CG Boissard, DJ Post-Munson, NA Meanwell, JE Starrett , ES Kozlowski, JL Romine, JT Trojnacki, MC Mckay, J Zhong and SI Dworetzky

Central Nervous System Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA. gribkoff_v@bms.com

Through expression of the cloned mouse (mSlo) or human (hSlo) large- conductance (BK) Ca(2+)-activated K+ channel in Xenopus laevis oocytes and HEK 293 cells, we characterized the effects of reported blockers and openers of BK channels to initiate the study of the molecular determinants of BK channel modulation. In oocytes, iberiotoxin and charybdotoxin, peptidyl scorpion toxins, were both equally effective blockers of BK current, although iberiotoxin was significantly more potent than charybdotoxin. The structurally related peptide kaliotoxin was not a potent blocker of BK current. Paxilline, a fungal tremorgenic alkaloid, was an effective but complex blocker of BK current. Tetrandrine, a putative blocker of type II BK channels, and ketamine were relatively ineffective. The putative BK openers NS004 and NS1619, phloretin, niflumic acid, flufenamic acid, and 5-nitro-2-(3- phenylpropylamino)benzoic acid (NPPB) increased BK current in oocytes at microM concentrations; many of these produced biphasic concentration- response relationships. Coapplication of representative blockers and openers revealed several patterns of interaction, including competitive and noncompetitive antagonism. NS1619, niflumic acid, and phloretin were tested by using excised inside-out membrane patches from HEK 293 cells and were found to increase the activity of hSlo BK channels and produce a leftward shift in the G/Gmax-versus-voltage relationship of these channels. These results represent the first comprehensive examination of the molecular pharmacology of BK channels.

Volume 50, Issue 1, pp. 206-217, 07/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				W. L. Imlach, S. C. Finch, J. Dunlop, A. L. Meredith, R. W. Aldrich, and J. E. Dalziel The Molecular Mechanism of "Ryegrass Staggers," a Neurological Disorder of K+ Channels J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 657 - 664. [Abstract] [Full Text] [PDF]

				S.-N. Wu, H. Peng, B.-S. Chen, Y.-J. Wang, P.-Y. Wu, and M.-W. Lin Potent Activation of Large-Conductance Ca2+-Activated K+ Channels by the Diphenylurea 1,3-Bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in Pituitary Tumor (GH3) Cells Mol. Pharmacol., December 1, 2008; 74(6): 1696 - 1704. [Abstract] [Full Text] [PDF]

				E. A. Matthews, A. P. Weible, S. Shah, and J. F. Disterhoft The BK-mediated fAHP is modulated by learning a hippocampus-dependent task PNAS, September 30, 2008; 105(39): 15154 - 15159. [Abstract] [Full Text] [PDF]

				M. Fukasawa, H. Nishida, T. Sato, M. Miyazaki, and H. Nakaya 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 100 - 104. [Abstract] [Full Text] [PDF]

				S. R. J. Taylor, M. Gonzalez-Begne, S. Dewhurst, G. Chimini, C. F. Higgins, J. E. Melvin, and J. I. Elliott Sequential Shrinkage and Swelling Underlie P2X7-Stimulated Lymphocyte Phosphatidylserine Exposure and Death J. Immunol., January 1, 2008; 180(1): 300 - 308. [Abstract] [Full Text] [PDF]

				M. L. Olson, M. E. Kargacin, C. A. Ward, and G. J. Kargacin Effects of Phloretin and Phloridzin on Ca2+ Handling, the Action Potential, and Ion Currents in Rat Ventricular Myocytes J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 921 - 929. [Abstract] [Full Text] [PDF]

				J. Ledoux, M. E. Werner, J. E. Brayden, and M. T. Nelson Calcium-Activated Potassium Channels and the Regulation of Vascular Tone Physiology, February 1, 2006; 21(1): 69 - 78. [Abstract] [Full Text] [PDF]

				A. Sato, K. Terata, H. Miura, K. Toyama, F. R. Loberiza Jr., O. A. Hatoum, T. Saito, I. Sakuma, and D. D. Gutterman Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1633 - H1640. [Abstract] [Full Text] [PDF]

				T. Sato, T. Saito, N. Saegusa, and H. Nakaya Mitochondrial Ca2+-Activated K+ Channels in Cardiac Myocytes: A Mechanism of the Cardioprotective Effect and Modulation by Protein Kinase A Circulation, January 18, 2005; 111(2): 198 - 203. [Abstract] [Full Text] [PDF]

				W. Xu, Y. Liu, S. Wang, T. McDonald, J. E. Van Eyk, A. Sidor, and B. O'Rourke Cytoprotective Role of Ca2+- Activated K+ Channels in the Cardiac Inner Mitochondrial Membrane Science, November 1, 2002; 298(5595): 1029 - 1033. [Abstract] [Full Text] [PDF]

				P. R. Junankar, A. Karjalainen, and K. Kirk The Role of P2Y1 Purinergic Receptors and Cytosolic Ca2+ in Hypotonically Activated Osmolyte Efflux from a Rat Hepatoma Cell Line J. Biol. Chem., October 18, 2002; 277(43): 40324 - 40334. [Abstract] [Full Text] [PDF]

				B. Hoepfl, B. Rodenwaldt, U. Pohl, and C. de Wit EDHF, but not NO or prostaglandins, is critical to evoke a conducted dilation upon ACh in hamster arterioles Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H996 - H1004. [Abstract] [Full Text] [PDF]

				B. Nilius and G. Droogmans Ion Channels and Their Functional Role in Vascular Endothelium Physiol Rev, October 1, 2001; 81(4): 1415 - 1459. [Abstract] [Full Text] [PDF]

				J. Marijic, Q. Li, M. Song, K. Nishimaru, E. Stefani, and L. Toro Decreased Expression of Voltage- and Ca2+-Activated K+ Channels in Coronary Smooth Muscle During Aging Circ. Res., February 2, 2001; 88(2): 210 - 216. [Abstract] [Full Text] [PDF]

				J. PAPASSOTIRIOU, R. KÖHLER, J. PRENEN, H. KRAUSE, M. AKBAR, J. EGGERMONT, M. PAUL, A. DISTLER, B. NILIUS, and J. HOYER Endothelial K+ channel lacks the Ca2+ sensitivity-regulating {beta} subunit FASEB J, May 1, 2000; 14(7): 885 - 894. [Abstract] [Full Text]

				S.-N. Wu, H.-F. Li, and Y.-C. Lo Characterization of Tetrandrine-Induced Inhibition of Large-Conductance Calcium-Activated Potassium Channels in a Human Endothelial Cell Line (HUV-EC-C) J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 188 - 195. [Abstract] [Full Text]

				K. Vaali, L. Li, I. Paakkari, and H. Vapaatalo Relaxing Effects of NO Donors on Guinea Pig Trachea In Vitro are Mediated by Calcium-Sensitive Potassium Channels J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 110 - 114. [Abstract] [Full Text]

				H.-S. Wang, J. E. Dixon, and D. McKinnon Unexpected and Differential Effects of Cl- Channel Blockers on the Kv4.3 and Kv4.2 K+ Channels : Implications for the Study of the Ito2 Current Circ. Res., November 19, 1997; 81(5): 711 - 718. [Abstract] [Full Text]